Origins and fates of cardiovascular progenitor cells

Sean M Wu1, Kenneth R Chien, Christine Mummery

  • 1Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA 02114, USA.

Cell
|February 26, 2008
PubMed

Insights

Multipotent cardiac progenitor cells exist in fetal and adult hearts. Understanding their distinct molecular identities is crucial for advancing cardiac cell therapy and drug screening.

Area of Science:

  • Cardiovascular Biology
  • Stem Cell Research
  • Developmental Biology

Background:

  • Multipotent cardiac progenitor cells are present in mammalian hearts (fetal and adult) and during embryonic stem cell differentiation.
  • These cardiac progenitor cells exhibit similar biological functions but possess distinct molecular profiles.
  • Understanding cardiac progenitor cell heterogeneity is essential for regenerative medicine and disease research.

Purpose of the Study:

  • To investigate the distinct molecular identities of various cardiac progenitor cell populations.
  • To elucidate the origins and lineage relationships of these cardiac progenitor cells.
  • To facilitate clinical applications and understand cardiac disease mechanisms.

Main Methods:

  • Comparative molecular profiling of cardiac progenitor cells from different sources.
  • Lineage tracing studies to determine developmental origins.
  • Functional assays to assess differentiation potential.

Main Results:

  • Identification of unique molecular markers for distinct cardiac progenitor cell populations.
  • Demonstration of specific developmental pathways governing cardiac progenitor cell differentiation.
  • Validation of progenitor cell populations for targeted therapeutic strategies.

Conclusions:

  • Cardiac progenitor cells, despite functional similarities, are molecularly diverse.
  • Elucidating these differences is key to unlocking their potential in cardiac cell therapy and drug discovery.
  • This research provides a foundation for understanding cardiac development and disease pathogenesis.

Related Concept Videos

Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
8.1K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
3.4K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.4K
Production of Formed Elements01:34

Production of Formed Elements

Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
7.4K
Development of Blood Vessels01:07

Development of Blood Vessels

The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
2.0K